MENU
+Compare
EAPIF
Stock ticker: OTC
AS OF
Jul 15 closing price
Price
$3.65
Change
-$0.09 (-2.41%)
Capitalization
1.11B

EAPIF EUROAPI SA Forecast, Technical & Fundamental Analysis

Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics... Show more

EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EAPIF with price predictions
Jul 25, 2025

EAPIF in downward trend: price may drop because broke its higher Bollinger Band on July 07, 2025

EAPIF broke above its upper Bollinger Band on July 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 4 similar instances where the stock broke above the upper band. In of the 4 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on July 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EAPIF as a result. In of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for EAPIF turned negative on July 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EAPIF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.953) is normal, around the industry mean (62.701). EAPIF has a moderately high P/E Ratio (476.190) as compared to the industry average of (88.783). EAPIF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (1.067) is also within normal values, averaging (18.372).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EAPIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
15 rue Traversiere
Phone
N/A
Employees
N/A
Web
https://www.euroapi.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGRRX29.040.15
+0.52%
Loomis Sayles Growth A
UIISX18.580.09
+0.49%
Victory Income Stock Institutional
DHMIX27.250.13
+0.48%
Diamond Hill Small-Mid Cap I
PLBBX38.950.18
+0.46%
Plumb Balanced Investor
RYOTX11.470.02
+0.17%
Royce Micro-Cap Invmt

EAPIF and Stocks

Correlation & Price change

A.I.dvisor tells us that EAPIF and ALVO have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and ALVO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
ALVO - EAPIF
23%
Poorly correlated
+4.91%
AKAN - EAPIF
19%
Poorly correlated
+0.79%
CLSH - EAPIF
7%
Poorly correlated
N/A
PLSH - EAPIF
6%
Poorly correlated
N/A
STEK - EAPIF
5%
Poorly correlated
-9.12%
More